Detection of SARS-CoV-2 Virus Amplification Using a Crumpled Graphene Field-Effect Transistor Biosensor
- Authors
- Park, Insu; Lim, Jongwon; You, Seungyong; Hwang, Michael Taeyoung; Kwon, Jaehong; Koprowski, K.; Kim, Sungdae; Heredia, J.; Stewart, De Ramirez S.A.; Valera, E.; Bashir, R.
- Issue Date
- Dec-2021
- Publisher
- American Chemical Society
- Keywords
- COVID-19; crumpled graphene FET biosensor; flat graphene FET biosensor; RT-LAMP; SARS-CoV-2; VTM clinical samples
- Citation
- ACS Sensors, v.6, no.12, pp.4461 - 4470
- Journal Title
- ACS Sensors
- Volume
- 6
- Number
- 12
- Start Page
- 4461
- End Page
- 4470
- URI
- https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/83504
- DOI
- 10.1021/acssensors.1c01937
- ISSN
- 2379-3694
- Abstract
- The rapid and unexpected spread of SARS-CoV-2 worldwide has caused unprecedented disruption to daily life and has brought forward critical challenges for public health. The disease was the largest cause of death in the United States in early 2021. Likewise, the COVID-19 pandemic has highlighted the need for rapid and accurate diagnoses at scales larger than ever before. To improve the availability of current gold standard diagnostic testing methods, the development of point-of-care devices that can maintain gold standard sensitivity while reducing the cost and providing portability is much needed. In this work, we combine the amplification capabilities of reverse transcriptase loop-mediated isothermal amplification (RT-LAMP) techniques with high-sensitivity end-point detection of crumpled graphene field-effect transistors (cgFETs) to develop a portable detection cell. This electrical detection method takes advantage of the ability of graphene to adsorb single-stranded DNA due to noncovalent π-πbonds but not double-stranded DNA. These devices have demonstrated the ability to detect the presence of the SARS-CoV-2 virus in a range from 10 to 104 copies/μL in 20 viral transport medium (VTM) clinical samples. As a result, we achieved 100% PPV, NPV, sensitivity, and specificity with 10 positive and 10 negative VTM clinical samples. Further, the cgFET devices can differentiate between positive and negative VTM clinical samples in 35 min based on the Dirac point shift. Likewise, the improved sensing capabilities of the crumpled gFET were compared with those of the traditional flat gFET devices. ©
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 바이오나노대학 > 바이오나노학과 > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.